ESC 365 - Risk of immune targeting of cardiovascular disease - What is acceptable?

ESC Premium Access

Risk of immune targeting of cardiovascular disease - What is acceptable?

Session: Targeting inflammation in cardiovascular disease - Is it feasible? And safe?

Topic: Pharmacology and Pharmacotherapy

Speaker: Professor W. Koenig (Munich, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)

24 presentations

0 follower

3 more presentations in this session

Non-pharmacological targeting of chronic inflammation and prevention of cardiovascular disease.

Speaker: Professor T. Guzik (Edinburgh, GB)

Looking beyond CANTOS - Where will immune targeting bring us?

Speaker: Doctor P. Ridker (Boston, US)

Precision medicine and cardiovascular immune targeted therapies.

Speaker: Professor G. Hansson (Stockholm, SE)

Access the full session

Targeting inflammation in cardiovascular disease - Is it feasible? And safe?

Speakers: Professor W. Koenig, Professor T. Guzik, Doctor P. Ridker, Professor G. Hansson

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources